Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR Shareholding
On 26 April 2024, the following executive director was granted options to subscribe for new ordinary shares of 12.5 pence each in Primary Health Properties PLC (the "Company" or "PHP") at a price of £0.7308 per share under the Company's 2024 Sharesave Plan, exercisable from May 2027 following the close of the associated three-year savings contract.
Details of the transaction referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).
| 1 | Details of person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Mark Davies
| |
| 2 | Reason for notification | ||
| (a) | Position/Status | Chief Executive Officer | |
| (b) | Initial notification/amendment | Initial notification
| |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
| (a) | Name
| Primary Health Properties PLC | |
| (b) | LEI | 213800Y5CJHXOATK7X11
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
| (b) | Nature of the transaction | Award of options over the Company's ordinary shares
| |
| (c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.7308 | 25,383 | ||
| (d) | Aggregated volume price | Single transaction: N/A
| |
| (e) | Date of transaction | 26 April 2024
| |
| (f) | Place of transaction | n/a
| |
For further information
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer
+44(0) 7729 047 959
Legal Entity Identifier: 213800Y5CJHXOATK7X11
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.